Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Gannet BioChem and Re-Vana Therapeutics Enter Development and cGMP Supply Agreement to Support Ophthalmic Drug Delivery Program

Summary by Financial Post
The agreement supports EyeLief® combination drug-device product development in anticipation of a future clinical program, with polymer supply also supporting OcuLief® and non-ocular applications HUNTSVILLE, Ala., Oct. 27, 2026 (GLOBE NEWSWIRE) — Gannet BioChem, a specialized contract development and manufacturing organization (CDMO) focused on activated polymers and bioconjugation, and Re-Vana Therapeutics, a biotechnology company developing […]

6 Articles

The Toronto StarThe Toronto Star
+5 Reposted by 5 other sources
Lean Left

Gannet BioChem and Re-Vana Therapeutics Enter Development and cGMP Supply Agreement to Support Ophthalmic Drug Delivery Program

HUNTSVILLE, Ala., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Gannet BioChem, a specialized contract development and manufacturing organization (CDMO) focused on activated polymers and bioconjugation, and Re-Vana Therapeutics, a biotechnology company developing sustained-release therapeutics and drug delivery technologies, today announced a…

·Toronto, Canada
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources lean Left
67% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Hamilton Spectator broke the news in Hamilton, Canada on Tuesday, October 27, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Huntsville, Alabama icon

Huntsville, Alabama

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal